Enhancing Data Collection Unveils Accurate Trends in Maternal Mortality in the US

A recent study conducted by researchers at the University of Oxford provides new insights into the patterns of maternal mortality in the United States, emphasizing the importance of accurate data collection. Published in JAMA Pediatrics, the study highlights how changes in reporting practices, particularly the introduction of a 'pregnancy checkbox' on death certificates, have significantly influenced the recorded rates of maternal deaths.
The research analyzed data spanning from 2000 to 2023, focusing on the impact of the pregnancy checkbox introduced at different times across U.S. states. By comparing states with and without this feature through a method called difference-in-differences analysis, the team found that the checkbox contributed to approximately 66% of the reported increase in maternal deaths between 2000 and 2019. This adjustment revealed that, aside from the pandemic period, maternal mortality rates remained relatively stable over the past two decades.
However, the COVID-19 pandemic marked a stark deviation, with adjusted maternal mortality rates peaking at 18.9 deaths per 100,000 live births in 2021—almost doubling the rate seen in previous years. This surge affected women across all racial and ethnic groups, except those aged 15–19, with Native American or Alaska Native women experiencing the most significant increase, with rates nearly tripling.
The study's lead authors emphasized that earlier assumptions about worsening maternal outcomes might have been influenced by reporting changes. The pandemic drastically affected maternal health, leading to higher death rates during that period. Yet, the findings suggest that under normal circumstances, maternal mortality rates have not substantially increased over recent years.
The research also pointed out persistent racial disparities. Non-Hispanic Black women consistently faced maternal mortality rates three to four times higher than non-Hispanic white women, with rates rising from 20.7 to 27.5 deaths per 100,000 live births during the pandemic. Conversely, infant mortality rates, which decreased during the same period, showed some small increases from 2021 onward.
Experts highlighted the importance of accurate data collection for public health. Robin Y. Park, a Ph.D. student and co-author, stated that accounting for reporting changes clarifies the true impact of health crises on maternal outcomes. The study underscores the need for investing in comprehensive health surveillance systems, particularly to address racial disparities and improve maternal and infant health indicators.
Using data from the National Vital Statistics Service, managed by the CDC, the study advocates for enhanced efforts in data collection and analysis. Such improvements are essential for formulating effective policies aimed at reducing maternal mortality and health disparities.
For more details, the full study is available in JAMA Pediatrics (2025), DOI: 10.1001/jamapediatrics.2025.0440.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Novartis Gains Approval for First Infant Malaria Treatment, Promising Hope for Vulnerable Babies
Novartis has received approval for the first malaria treatment designed specifically for newborns and infants, offering new hope in the global fight against malaria, especially in African countries with high mortality rates.
Increase in Mammal Bird Flu Outbreaks Elevates Human Health Risks: New Report
Recent reports reveal a doubling of bird flu outbreaks in mammals worldwide, heightening the risk of human transmission and emphasizing the importance of vaccination and enhanced surveillance efforts.
Novel Drug Candidate Shows Promise in Combatting Aggressive Brain Tumors by Targeting Cellular Motors
A groundbreaking study introduces MT-125, a new experimental drug that targets cellular motors to fight aggressive brain tumors, opening new pathways for glioblastoma treatment.
Stem Cell Transplant as a Promising Cure for Pediatric Monogenic Inflammatory Bowel Disease
Research shows hematopoietic stem cell transplantation as a promising, potentially curative therapy for children with severe monogenic inflammatory bowel disease, offering new hope for early intervention.